{
    "title": "104_hr1914",
    "content": "SECTION 1. SHORT TITLE AND PURPOSE.\n\n    (a) Short Title.--This Act may be cited as the ``Safe Medications \nAct of 1995''.\n    (b) Purpose.--It is the purpose of this Act to have the Secretary \nof Health and Human Services create a data bank for reports of deaths \nfrom the prescribing, dispensing, and administration of drugs, to \nestablish a program using such data to assist in preventing such \ndeaths, and to educate and inform health care professionals of the \ndeaths that may occur in the course of drug therapy.\n\nSEC. 2. REPORTING.\n\n    (a) In General.--Any pharmacy, hospital, long-term care facility, \nphysician's office, or other health care facility, as defined by the \nSecretary of Health and Human Services by regulation, in which a death \noccurs as a result of the prescribing, dispensing, or administration of \na drug to an individual shall report such deaths to the Secretary of \nHealth and Human Services under section 3. Such a report shall be made \nnot later than 10 working days after the date of the discovery of the \ndeaths.\n    (b) Report Requirements.--Each report of a death from the \nprescribing, dispensing, or administration of a drug to an individual \nshall at least contain--\n            (1) an identification of the person making the report, \n        including the address and telephone number of such person, and \n        the name and address of the facility in which the drug was \n        prescribed, dispensed, or administered;\n            (2) a description of the error in the prescription, \n        dispensing, or administration of the drug if an error occurred \n        to include the following:\n                    (A) the misunderstanding (if any) of an oral \n                communication for the prescription of the drug \n                involved,\n                    (B) the misinterpretation or misreading (if any) of \n                a written prescription for the drug involved,\n                    (C) the improper identification (if any) of the \n                drug involved because of shelf placement,\n                    (D) the confusion (if any) over the drug involved \n                because of product packaging or drug name, and\n                    (E) when and how the error was discovered,\n            (3) the brand name of the drug involved (if any), the \n        generic name of such drug, the manufacturers of such drug, the \n        labeler of such drug if different from the manufacturer, the \n        dosage form of such drug, the strength of such drug, and the \n        type and size of the drug containers;\n            (4) the lot number of the drug involved, if available;\n            (5) information on the patient for whom the drug involved \n        was prescribed, dispensed, or administered, including the \n        patient's age and sex,\n            (6) the diagnosis for which the drug involved was \n        prescribed, dispensed, or administered, and\n            (7) the date and time of the death.\nReporting requirements shall be updated as directed by the Secretary.\n\nSEC. 3. DATA BANK.\n\n    (a) Establishment.--The Secretary of Health and Human Services \nshall establish and maintain in cooperation with the compiler of the \nofficial compendia of drug standards a data bank to receive reports \nunder section 2 of deaths. If such compiler will not cooperate in \nconnection with such data bank, the Secretary shall establish or by \ncontract provide for such data bank.\n    (b) Secretarial Action.--The Secretary shall review information \nreported to the data bank on an ongoing basis to determine trends \nrelating to drugs and shall report such information to the compiler of \nthe official compendia of drug standards on an ongoing basis for \nconsideration of revision of the packaging and labeling requirements or \nother standards for drugs for dissemination to physicians, pharmacists, \nand other health professionals involved in the prescribing, dispensing, \nand administration of drugs to patients. Such reporting of aggregate \ndata shall be done in a manner which assists such health professionals \nin identifying and reducing patterns and incidents of inappropriate use \nassociated with certain drugs.\n    (c) Confidentiality.--The identity of a person making a report to \nthe data bank, the deceased, and the individual who prescribed, \ndispensed, or administered the drug shall be considered as privileged \nand confidential information for purposes of any law requiring \ndisclosure of information.\n    (d) Shared Information.--The Secretary shall share the reported \ninformation with governmental licensing, accreditation, and inspection \nagencies for their action with the appropriate organizations to ensure \nthat there has not been a failure to report such deaths.\n    (e) Enforcement.--Whoever with false pretenses reports to the data \nbank, requests information from the data bank, or unlawfully gains \naccess to the data bank shall be fined not more than $15,000 or \nimprisoned for not more than 3 years, or both, except that if a person \ncommits a violation of this subsection after a conviction for a \nviolation of this subsection has become final, such person shall be \nfined not more than $25,000 or imprisoned for not more than 3 years, or \nboth.\n\nSEC. 4. PENALTIES.\n\n    (a) Imposition of Fine.--Any institution that does not make a \nreport as required by section 2 shall be subject to a fine of $15,000 \nfor each report not made. Within 60 days of a conviction under this \nsubsection, a person shall submit to the Secretary of Health and Human \nServices a plan for the reporting to the data bank of deaths from drugs \nand drug prescribing, dispensing, and administration errors.\n    (b) Mandatory Exclusion from Medicare and State Health Care \nPrograms.--Section 1128(a) of the Social Security Act (42 U.S.C. 1320a-\n7(a)) is amended by adding at the end the following new paragraph:\n            ``(3) Failure to report deaths resulting from the \n        prescribing, dispensing, and administration of drugs.--Any \n        individual or entity that has failed or refused to respond to a \n        subpoena for information on a reportable incident or has failed \n        to meet the requirements of section 2 of the Safe Medications \n        Act of 1995.''."
}